Terms: = Thyroid cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
4 results:
1. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract] [Full Text] [Related]
2. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
Hegde A; Andreev-Drakhlin AY; Roszik J; Huang L; Liu S; Hess K; Cabanillas M; Hu MI; Busaidy NL; Sherman SI; Dadu R; Grubbs EG; Ali SM; Lee J; Elamin YY; Simon GR; Blumenschein GR; Papadimitrakopoulou VA; Hong D; Meric-Bernstam F; Heymach J; Subbiah V
ESMO Open; 2020 Oct; 5(5):e000799. PubMed ID: 33097651
[TBL] [Abstract] [Full Text] [Related]
3. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
[TBL] [Abstract] [Full Text] [Related]
4. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts.
Gencer B; Collet TH; Virgini V; Bauer DC; Gussekloo J; Cappola AR; Nanchen D; den Elzen WP; Balmer P; Luben RN; Iacoviello M; Triggiani V; Cornuz J; Newman AB; Khaw KT; Jukema JW; Westendorp RG; Vittinghoff E; Aujesky D; Rodondi N;
Circulation; 2012 Aug; 126(9):1040-9. PubMed ID: 22821943
[TBL] [Abstract] [Full Text] [Related]
